These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9918237)

  • 1. Matrix metalloproteinases, tissue inhibitors of metalloproteinases, and glycosaminoglycans in synovial fluid from patients with rheumatoid arthritis.
    Ishiguro N; Ito T; Miyazaki K; Iwata H
    J Rheumatol; 1999 Jan; 26(1):34-40. PubMed ID: 9918237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of stromelysin-1, 72 and 92 kDa type IV collagenase, tissue inhibitor of metalloproteinase-1 (TIMP-1), and TIMP-2 in synovial fluid and serum from patients with rheumatoid arthritis.
    Ishiguro N; Ito T; Obata K; Fujimoto N; Iwata H
    J Rheumatol; 1996 Sep; 23(9):1599-604. PubMed ID: 8877931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover and inflammation as revealed by analyses of synovial fluids from patients with rheumatoid arthritis.
    Ishiguro N; Ito T; Oguchi T; Kojima T; Iwata H; Ionescu M; Poole AR
    Arthritis Rheum; 2001 Nov; 44(11):2503-11. PubMed ID: 11710706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of progression of damage to articular cartilage 2 years after anterior cruciate ligament reconstruction: use of aggrecan and type II collagen biomarkers in a retrospective observational study.
    Sobue Y; Kojima T; Kurokouchi K; Takahashi S; Yoshida H; Poole R; Ishiguro N
    Arthritis Res Ther; 2017 Dec; 19(1):265. PubMed ID: 29208010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of age and sex on chondroitin sulfates in normal synovial fluid.
    Nakayama Y; Narita T; Mori A; Uesaka S; Miyazaki K; Ito H
    Arthritis Rheum; 2002 Aug; 46(8):2105-8. PubMed ID: 12209515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis.
    Yoshihara Y; Nakamura H; Obata K; Yamada H; Hayakawa T; Fujikawa K; Okada Y
    Ann Rheum Dis; 2000 Jun; 59(6):455-61. PubMed ID: 10834863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synovial fluid chondroitin and keratan sulphate epitopes, glycosaminoglycans, and hyaluronan in arthritic and normal knees.
    Belcher C; Yaqub R; Fawthrop F; Bayliss M; Doherty M
    Ann Rheum Dis; 1997 May; 56(5):299-307. PubMed ID: 9175930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between pre-radiographic cartilage damage following anterior cruciate ligament injury and biomarkers of cartilage turnover in clinical practice: a cross-sectional observational study.
    Yoshida H; Kojima T; Kurokouchi K; Takahashi S; Hanamura H; Kojima M; Poole AR; Ishiguro N
    Osteoarthritis Cartilage; 2013 Jun; 21(6):831-8. PubMed ID: 23523852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of circulating collagenase, stromelysin-1, and tissue inhibitor of matrix metalloproteinases 1 in patients with rheumatoid arthritis. Relationship to serum levels of antigenic keratan sulfate and systemic parameters of inflammation.
    Manicourt DH; Fujimoto N; Obata K; Thonar EJ
    Arthritis Rheum; 1995 Aug; 38(8):1031-9. PubMed ID: 7639798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in biochemical markers and prediction of effectiveness of intra-articular hyaluronan in patients with knee osteoarthritis.
    Hasegawa M; Nakoshi Y; Tsujii M; Sudo A; Masuda H; Yoshida T; Uchida A
    Osteoarthritis Cartilage; 2008 Apr; 16(4):526-9. PubMed ID: 17951079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover: analyses of synovial fluid from patients with osteoarthritis.
    Ishiguro N; Ito T; Ito H; Iwata H; Jugessur H; Ionescu M; Poole AR
    Arthritis Rheum; 1999 Jan; 42(1):129-36. PubMed ID: 9920023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of hyaluronan, antigenic keratan sulfate, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinases 1 change predictably in rheumatoid arthritis patients who have begun activity after a night of bed rest.
    Manicourt DH; Poilvache P; Nzeusseu A; van Egeren A; Devogelaer JP; Lenz ME; Thonar EJ
    Arthritis Rheum; 1999 Sep; 42(9):1861-9. PubMed ID: 10513800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synovial fluid cartilage metabolism marker concentrations in osteonecrosis of the femoral head compared with osteoarthrosis of the hip.
    Iwase T; Hasegawa Y; Ishiguro N; Ito T; Iwasada S; Kitamura S; Iwata H
    J Rheumatol; 1998 Mar; 25(3):527-31. PubMed ID: 9517775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycosaminoglycan components in temporomandibular joint synovial fluid as markers of joint pathology.
    Shibata T; Murakami KI; Kubota E; Maeda H
    J Oral Maxillofac Surg; 1998 Feb; 56(2):209-13. PubMed ID: 9461147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis.
    Manicourt DH; Poilvache P; Van Egeren A; Devogelaer JP; Lenz ME; Thonar EJ
    Arthritis Rheum; 2000 Feb; 43(2):281-8. PubMed ID: 10693867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in synovial fluid biochemical markers following arthroscopic surgery in patients with knee osteoarthritis.
    Nakajima A; Nakagawa K; Aoki Y; Sonobe M; Shibata Y; Yamazaki M; Murakami M
    Rheumatol Int; 2013 Jan; 33(1):209-14. PubMed ID: 22441960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in cartilage metabolism in arthritis are reflected by altered serum and synovial fluid levels of the cartilage proteoglycan aggrecan. Implications for pathogenesis.
    Poole AR; Ionescu M; Swan A; Dieppe PA
    J Clin Invest; 1994 Jul; 94(1):25-33. PubMed ID: 7518830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of interstitial collagenase (MMP-1) in patients with rheumatoid arthritis.
    Maeda S; Sawai T; Uzuki M; Takahashi Y; Omoto H; Seki M; Sakurai M
    Ann Rheum Dis; 1995 Dec; 54(12):970-5. PubMed ID: 8546529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
    Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
    Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of antithrombin by hyaluronic acid may be involved in the pathogenesis of rheumatoid arthritis.
    Chang X; Yamada R; Yamamoto K
    Arthritis Res Ther; 2005; 7(2):R268-73. PubMed ID: 15743473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.